09.Issue 08 august 22 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 09, Issue : 08, August – 2022

Title:

09.DEVELOPMENT OF PHARMACOGNOSTICAL PROFILE, ANALYTICAL AND PHARMACOLOGICAL EVALUATION OF NEPHROPROTECTIVE MEDICINAL PLANT PORTULACA OLERACIA
‏‬

Authors :

Dr. Md. Rageeb Md. Usman*, Dr. G. P. Vadnare, Swapnil K. Patil

Abstract :

The objective of present study deals with the development of a Pharmacognostical profile as well as and analytical and pharmacological evaluation of the Nephroprotective medicinal plant Portulaca oleracea are the goals were to collect and authenticate the investigational plant, evaluate Portulaca oleracea’s Pharmacognostical profile (macroscopic and microscopic), conduct a preliminary physico-chemical analysis of the plant, and extract its active ingredients. To standardise plant extracts through phytochemical investigations, develop an active Nephroprotective drug from Portulaca oleracea extracts, and assess Portulaca oleracea extract for Nephroprotective activity in vitro.
Keywords: Portulaca oleracea, Nephroprotective, Pharmacognostical, GGT, Analytical evaluation.

Cite This Article:

Please cite this article in press Md. Rageeb Md. Usman et al, Development Of Pharmacognostical Profile, Analytical And Pharmacological Evaluation Of Nephroprotective Medicinal Plant Portulaca Oleracia)., Indo Am. J. P. Sci, 2022; 09(8).,

Number of Downloads : 10

References:

1) Okafor IA, Ayalokunrin MB, Orachu LA. A review on Portulaca oleracea (purslane) plant-Its nature and biomedical benefits. Int J Biomed Res. 2014;5 (2):75-80.
2) World Health Organization. Quality control methods for medicinal plant materials. World Health Organization; 1998.
3) The Ayurvedic Pharmacopoeia of India. Ministry of Health and Family Welfare. Department of AYUSH. New Delhi, India: Government of India; Volume 1-6.
4) Brain KR, Turner TD. The practical evaluation of phytopharmaceuticals. Bristol: Wright-Scientechnica; 1975.
5) Khandelwal KR. Practical Pharmacognosy. 19″ ed. Pune, India: Nirali Prakashan. 2008: 49-70.
6) Ai J, Leng A, Gao X, Zhang W, Li D, Xu L, Ying X. HPLC determination of the eight constitutes in Portulaca oleracea L. from different locations. European Journal of Medicinal Plants. 2015 Jan 1; 5(2):156.
7) Hanigan MH, Frierson Jr HF. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. Journal of Histochemistry & Cytochemistry. 1996 Oct; 44 (10):1101-8.
8) Al-Dallee ZT, Khalaf KT, Dawood YA, Ramadhan UH. Phytochemical analysis of Portulaca oleracea L. leaves extract and study the role in protecting genomic human DNA from UV damage. Journal of Basrah Researches ((Sciences)). 2022;48(1).
9) Vahedi-Mazdabadi Y, Saeedi M. Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study. Evidence-Based Complementary and Alternative Medicine. 2021 Nov 9;2021.
10) Derouiche S, Degachi O, Gharbi K. The effect of Purslane and Aquilaria malaccensis on insulin-resistance and lipid peroxidation in High-fructose diet Rats. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2020 Dec 30;27(4):357-65..
11) Chugh V, Mishra V, Dwivedi SV, Sharma KD. Purslane (Portulaca oleracea L.): An underutilized wonder plant with potential pharmacological value. Pharm. Innov. J. 2019;8:236-46.
12) Djellouli F, Krouf D, Lacaille-Dubois MA, Bouchenak M. Portulaca oleracea reduces lipemia, glycemia, and oxidative stress in streptozotocininduced diabetic rats fed cholesterol-enriched diet. J Pharmaceut Res International. 2018 Jan 1;23(4):1-2..
13) Assinewe VA, Baum BR, Gagnon D, Arnason JT. Phytochemistry of wild populations of Panax quinquefolius L.(North American ginseng). Journal of Agricultural and Food Chemistry. 2003 Jul 30;51(16):4549-53.
14) Sultana AR, Rahman K. Portulaca oleracea Linn. A global Panacea with ethno- medicinal and pharmacological potential. Int J Pharm Pharm Sci. 2013;5(2):33-9.
15) Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. Journal of ethnobiology and ethnomedicine. 2006 Dec;2(1):1-1.
16) Hanigan MH, Frierson Jr HF. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. Journal of Histochemistry & Cytochemistry. 1996 Oct; 44 (10):1101-8.
17) Al-Dallee ZT, Khalaf KT, Dawood YA, Ramadhan UH. Phytochemical analysis of Portulaca oleracea L. leaves extract and study the role in protecting genomic human DNA from UV damage. Journal of Basrah Researches ((Sciences)). 2022;48(1).
18) Vahedi-Mazdabadi Y, Saeedi M. Treatment of Lupus Nephritis from Iranian Traditional Medicine and Modern Medicine Points of View: A Comparative Study. Evidence-Based Complementary and Alternative Medicine. 2021 Nov 9;2021.
19) Derouiche S, Degachi O, Gharbi K. The effect of Purslane and Aquilaria malaccensis on insulin-resistance and lipid peroxidation in High-fructose diet Rats. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2020 Dec 30;27(4):357-65..
20) Chugh V, Mishra V, Dwivedi SV, Sharma KD. Purslane (Portulaca oleracea L.): An underutilized wonder plant with potential pharmacological value. Pharm. Innov. J. 2019;8:236-46.
21) Djellouli F, Krouf D, Lacaille-Dubois MA, Bouchenak M. Portulaca oleracea reduces lipemia, glycemia, and oxidative stress in streptozotocininduced diabetic rats fed cholesterol-enriched diet. J Pharmaceut Res International. 2018 Jan 1;23(4):1-2..
22) Assinewe VA, Baum BR, Gagnon D, Arnason JT. Phytochemistry of wild populations of Panax quinquefolius L.(North American ginseng). Journal of Agricultural and Food Chemistry. 2003 Jul 30;51(16):4549-53.
23) Sultana AR, Rahman K. Portulaca oleracea Linn. A global Panacea with ethno- medicinal and pharmacological potential. Int J Pharm Pharm Sci. 2013;5(2):33-9.
24) Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. Journal of ethnobiology and ethnomedicine. 2006 Dec;2(1):1-1.
25) Imai S, Shiraishi A, Gamo K, Watanabe I, Okuhata H, Miyasaka H, Ikeda K, Bamba T, Hirata K. Removal of phenolic endocrine disruptors by Portulaca oleracea. Journal of bioscience and bioengineering. 2007 May 1;103(5):420-6.
26) Wang W, Gu L, Dong L, Wang X. Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism. Asia Pacific Journal of Clinical Nutrition. 2007;16:227.
27) Banerjee G, Mukherjee A. Biological activity of a common weed-Portulaca oleracea
28) L. II. Antifungal activity. Acta Botanica Hungarica. 2002 Nov 1;44(3- 4):205-8.
29) Parry O, Marks JA, Okwuasaba FK. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. Journal of ethnopharmacology. 1993 Dec 1;40(3):187-94.
30) Iranshahy M, Javadi B, Iranshahi M, Jahanbakhsh SP, Mahyari S, Hassani FV, Karimi G. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. Journal of ethnopharmacology. 2017 Jun 9;205:158-72.
31) Ai J, Leng A, Gao X, Zhang W, Li D, Xu L, Ying X. HPLC determination of the eight constitutes in Portulaca oleracea L. from different locations. European Journal of Medicinal Plants. 2015 Jan 1;5(2):156.
32) Rasha Hamed Mahmoud & Lamiaa Barakat AA. The antiatherogenic, renal protective and immunomodulatory effects of purslane on hypercholesteromic rats, North American Journal of Medical Sciences 2011; 3(9):351-357.
33) World Health Organization. Quality control methods for medicinal plant materials. World Health Organization; 1998.
34) The Ayurvedic Pharmacopoeia of India. Ministry of Health and Family Welfare. Department of AYUSH. New Delhi, India: Government of India; Volume 1-6.
35) Brain KR, Turner TD. The practical evaluation of phytopharmaceuticals. Bristol: Wright-Scientechnica; 1975.
36) Khandelwal KR. Practical Pharmacognosy. 19″ ed. Pune, India: Nirali Prakashan. 2008:49-70.
37) Hanigan MH, Frierson Jr HF. Immunohistochemical detection of gamma-glutamyl transpeptidase in normal human tissue. Journal of Histochemistry & Cytochemistry. 1996 Oct;44(10):1101-8.